{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-025652","form_type":"8-K","ticker":"AXGN","cik":"0000805928","company_name":"Axogen, Inc.","filed_at":"2022-07-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.187415+00:00","generated_at":"2026-06-24T17:52:17.779408+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Axogen appoints William Burke to Board of Directors, effective July 11, 2022","bullets":["William Burke, former EVP & CFO of Haemonetics, appointed as director effective July 11, 2022.","Burke will chair the Audit Committee; board committees were reconstituted.","Burke brings 25+ years of finance leadership from Medtronic, Covidien, and Haemonetics.","Compensation includes $10,000 quarterly retainer, $5,000 as Audit Committee chair, plus equity grants."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-025652","json":"https://secwatch.observer/filing/0001140361-22-025652.json","markdown":"https://secwatch.observer/filing/0001140361-22-025652.md","text":"https://secwatch.observer/filing/0001140361-22-025652.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/0001140361-22-025652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/brhc10039541_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T17:52:17.779408+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0e0e6ccf9f","claim":"William Burke was appointed as Director at Axogen, Inc..","evidence_excerpt":"On July 8, 2022, the board of directors (the “Board”) of Axogen, Inc. (the “Company”) appointed William Burke as a new director to fill the vacant directorship on the Board, effective July 11, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/805928/000114036122025652/0001140361-22-025652-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}